ATE361119T1 - Prävention und therapie von leberzirrhosen - Google Patents

Prävention und therapie von leberzirrhosen

Info

Publication number
ATE361119T1
ATE361119T1 AT99919561T AT99919561T ATE361119T1 AT E361119 T1 ATE361119 T1 AT E361119T1 AT 99919561 T AT99919561 T AT 99919561T AT 99919561 T AT99919561 T AT 99919561T AT E361119 T1 ATE361119 T1 AT E361119T1
Authority
AT
Austria
Prior art keywords
cirrhosis
liver
prevention
treatment
preventives
Prior art date
Application number
AT99919561T
Other languages
English (en)
Inventor
Yoshiyuki Ueno
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Application granted granted Critical
Publication of ATE361119T1 publication Critical patent/ATE361119T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99919561T 1998-05-14 1999-05-13 Prävention und therapie von leberzirrhosen ATE361119T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13177198 1998-05-14

Publications (1)

Publication Number Publication Date
ATE361119T1 true ATE361119T1 (de) 2007-05-15

Family

ID=15065784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99919561T ATE361119T1 (de) 1998-05-14 1999-05-13 Prävention und therapie von leberzirrhosen

Country Status (5)

Country Link
EP (1) EP1077069B1 (de)
AT (1) ATE361119T1 (de)
CA (1) CA2328601A1 (de)
DE (1) DE69935976D1 (de)
WO (1) WO1999058150A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08127594A (ja) * 1993-11-10 1996-05-21 Mochida Pharmaceut Co Ltd Ｆａｓ抗原に結合する新規蛋白質およびそれをコードするＤＮＡ
JP3925663B2 (ja) * 1995-06-30 2007-06-06 持田製薬株式会社 抗Ｆａｓリガンド抗体および該抗体を用いた測定法
JPH0972901A (ja) * 1995-09-01 1997-03-18 Nippon Dpc Corp 肝疾患群の評価法
JPH09124509A (ja) * 1995-10-27 1997-05-13 Sumitomo Electric Ind Ltd 肝炎治療剤
EP0965637B1 (de) * 1996-05-02 2005-07-20 Mochida Pharmaceutical Co., Ltd. Fas ANTIGEN-DERIVATE

Also Published As

Publication number Publication date
DE69935976D1 (de) 2007-06-14
EP1077069A1 (de) 2001-02-21
CA2328601A1 (en) 1999-11-18
WO1999058150A1 (fr) 1999-11-18
EP1077069A4 (de) 2004-06-16
EP1077069B1 (de) 2007-05-02

Similar Documents

Publication Publication Date Title
CY1110309T1 (el) Φαρμακευτικες συνθεσεις για την προληψη και την αγωγη διαταραχων του κεντρικου νευρικου συστηματος περιλαμβανοντας ενα αναλογο νικοτινης και εναν αναστολεα ακετυλχολινεστερασης
SE9901272D0 (sv) New improved formulation
SI1509232T1 (sl) Kombinacija antagonista nmda in zaviralcev acetilholinesteraze za zdravljenje alzheimerjeve bolezni
DE69838099D1 (de) Quinazolinenon-enthaltende pharmazeutische zusammensetzungen zur verhütung von gefässneubildung und zur behandlung von bösartigen neubildungen
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
ATE240115T1 (de) Zusammensetzung zur vorbeugung und/oder behandlung der atherosklerose
NO952890D0 (no) Kombinasjonsbehandling for inhibisjon av bentap
FI951856A0 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
ES2136252T3 (es) Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa.
WO2001030333A3 (en) Tissue factor antagonists and methods of use thereof
DE69935140D1 (de) Verwendung von anabolika, anti-katabolischen mitteln, antioxidanzien und analgetika zum schutz, zur behandlung und reparation von bindegeweben in menschen und tieren
ID29547A (id) Metoda dan komposisi untuk pencegahan dan pengobatan tuberkulosis
BR9916432A (pt) Compostos de triazinona para o tratamento de doenças devido ao sarcosystis, neospora e ao toxoplasma
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
DE60142308D1 (de) Vorbeugungs- oder heilmittel gegen endometriose
ATE361119T1 (de) Prävention und therapie von leberzirrhosen
BR0015121A (pt) Composição farmacêutica utilizável para o tratamento de inflamação em humanos, e, método de tratamento de inflamação
DE69928685D1 (de) Heilmittel und/oder vorbeugungsmittel gegen fettleibigkeit
GB9602444D0 (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections
ATE333287T1 (de) Prophylaxe und behandlung von autoimmunen entmyelinisierungserkrankungen durch fas- antagonisten
BR0003648A (pt) Composições e métodos para tratar condições alérgicas e inflamatórias com tosse
IT1306143B1 (it) Composizione per la prevenzione ed il trattamento delle alterazionimentali e comportamentali.
IL122883A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
IL127102A0 (en) Pharmaceutical compositions for the treatment of dyskinesias
IL137190A0 (en) Pharmaceutical compositions for the treatment of dyskinesias

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties